We manufacture products that are in all the top ten therapeutic areas by sales in the Indian formulation market in Fiscal 2023 as identified by CRISIL Research.
We have developed a diversified branded generics product portfolio including tablets, capsules, dry syrups, dry powder injection.ointments, and liquid orals. -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Our products cover the following therapeutic areas:
Cephalosporins
Proton Pump Inhibitor
Anticholinergic and Heparin NSAIDs,
Analgesics and Antipyretic
Anticold and Antiallergic
Antiemetic
Antidiabetic
Antispasmodic
Antifibrinolytic
Cardiovascular
Antioxidant and Vitamins
Antihyperuricemia and Antigout
Fluoroquinolone and Macrolide
Nootropics and Neurotonics / Neurotrophics
Antiulcerative
Antimalarial Anxiolytic,
Anticonvulsant and Antipsychotic
Bladder and Prostate Disorder
Antifungal, anthelmintic and Antiviral Anticholinergic,